124 related articles for article (PubMed ID: 37230951)
1. Copper-inducible expression system for metabolic engineering of Escherichia coli.
Liu L; Zhang L; Wang J; Cao M; Yuan J
J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37230951
[TBL] [Abstract][Full Text] [Related]
2. An autoinducible trp-T7 expression system for production of proteins and biochemicals in Escherichia coli.
Landberg J; Mundhada H; Nielsen AT
Biotechnol Bioeng; 2020 May; 117(5):1513-1524. PubMed ID: 32022248
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli chromosome-based T7-dependent constitutive overexpression system and its application to generating a phenylalanine producing strain.
Koma D; Kishida T; Yamanaka H; Moriyoshi K; Nagamori E; Ohmoto T
J Biosci Bioeng; 2018 Nov; 126(5):586-595. PubMed ID: 29958770
[TBL] [Abstract][Full Text] [Related]
4. Production of phloroglucinol by Escherichia coli using a stationary-phase promoter.
Cao Y; Xian M
Biotechnol Lett; 2011 Sep; 33(9):1853-8. PubMed ID: 21544607
[TBL] [Abstract][Full Text] [Related]
5. Metabolic manipulation through CRISPRi and gene deletion to enhance cadaverine production in Escherichia coli.
Ting WW; Ng IS
J Biosci Bioeng; 2020 Dec; 130(6):553-562. PubMed ID: 32792329
[TBL] [Abstract][Full Text] [Related]
6. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
[TBL] [Abstract][Full Text] [Related]
7. Regulating the T7 RNA polymerase expression in E. coli BL21 (DE3) to provide more host options for recombinant protein production.
Du F; Liu YQ; Xu YS; Li ZJ; Wang YZ; Zhang ZX; Sun XM
Microb Cell Fact; 2021 Sep; 20(1):189. PubMed ID: 34565359
[TBL] [Abstract][Full Text] [Related]
8. Plasmids for Controlled and Tunable High-Level Expression in E. coli.
Schuster LA; Reisch CR
Appl Environ Microbiol; 2022 Nov; 88(22):e0093922. PubMed ID: 36342148
[TBL] [Abstract][Full Text] [Related]
9. Optimizing membrane protein overexpression in the Escherichia coli strain Lemo21(DE3).
Schlegel S; Löfblom J; Lee C; Hjelm A; Klepsch M; Strous M; Drew D; Slotboom DJ; de Gier JW
J Mol Biol; 2012 Nov; 423(4):648-59. PubMed ID: 22858868
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway.
Dvorak P; Chrast L; Nikel PI; Fedr R; Soucek K; Sedlackova M; Chaloupkova R; de Lorenzo V; Prokop Z; Damborsky J
Microb Cell Fact; 2015 Dec; 14():201. PubMed ID: 26691337
[TBL] [Abstract][Full Text] [Related]
11. Development of orthogonal T7 expression system in Klebsiella pneumoniae.
Zhao P; Ren M; Ge X; Tian P; Tan T
Biotechnol Bioeng; 2020 Aug; 117(8):2446-2459. PubMed ID: 32437011
[TBL] [Abstract][Full Text] [Related]
12. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Fiege K; Frankenberg-Dinkel N
Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
[TBL] [Abstract][Full Text] [Related]
13. The tunable pReX expression vector enables optimizing the T7-based production of membrane and secretory proteins in E. coli.
Kuipers G; Karyolaimos A; Zhang Z; Ismail N; Trinco G; Vikström D; Slotboom DJ; de Gier JW
Microb Cell Fact; 2017 Dec; 16(1):226. PubMed ID: 29246156
[TBL] [Abstract][Full Text] [Related]
14. ASIA: An automated stress-inducible adaptor for enhanced stress protein expression in engineered Escherichia coli.
Hsiang CC; Ng IS
Biotechnol Bioeng; 2024 Jun; 121(6):1902-1911. PubMed ID: 38450753
[TBL] [Abstract][Full Text] [Related]
15. Production of shikimic acid from Escherichia coli through chemically inducible chromosomal evolution and cofactor metabolic engineering.
Cui YY; Ling C; Zhang YY; Huang J; Liu JZ
Microb Cell Fact; 2014 Feb; 13():21. PubMed ID: 24512078
[TBL] [Abstract][Full Text] [Related]
16. Engineering a CRISPRi Circuit for Autonomous Control of Metabolic Flux in
Gao C; Guo L; Hu G; Liu J; Chen X; Xia X; Liu L
ACS Synth Biol; 2021 Oct; 10(10):2661-2671. PubMed ID: 34609846
[TBL] [Abstract][Full Text] [Related]
17. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
[TBL] [Abstract][Full Text] [Related]
18. Sort-Seq Approach to Engineering a Formaldehyde-Inducible Promoter for Dynamically Regulated Escherichia coli Growth on Methanol.
Rohlhill J; Sandoval NR; Papoutsakis ET
ACS Synth Biol; 2017 Aug; 6(8):1584-1595. PubMed ID: 28463494
[TBL] [Abstract][Full Text] [Related]
19. Development of inducer-free expression plasmids based on IPTG-inducible promoters for Bacillus subtilis.
Tran DTM; Phan TTP; Huynh TK; Dang NTK; Huynh PTK; Nguyen TM; Truong TTT; Tran TL; Schumann W; Nguyen HD
Microb Cell Fact; 2017 Jul; 16(1):130. PubMed ID: 28743271
[TBL] [Abstract][Full Text] [Related]
20. CRISPR interference-guided modulation of glucose pathways to boost aconitic acid production in Escherichia coli.
Li Q; Zhao P; Yin H; Liu Z; Zhao H; Tian P
Microb Cell Fact; 2020 Sep; 19(1):174. PubMed ID: 32883305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
